Abiopharma

🔍 Cunningham Kent Douglas (Executive)

Company: SRx Health Solutions, Inc. (SRXH)

Report Date: 2024-06-24

Detailed Transactions and Holdings:

• Acquired 200,000 shares of Common Stock at $0.39 per share (Direct)
  Date: 2025-12-03 | Code: A | equity_swap_involved: 0 | shares_owned_after: 655,060.00 | transaction_form_type: 4
• Acquired 44,464 shares of Common Stock at $0.33 per share (Direct)
  Date: 2025-09-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 455,060.00 | transaction_form_type: 4
• Acquired 231,193 shares of Common Stock at $0.404 per share (Direct)
  Date: 2025-08-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 410,596.00 | transaction_form_type: 4
• Acquired 84,906 shares of Common Stock at $1.59 per share (Direct)
  Date: 2025-04-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 179,403.00 | transaction_form_type: 4
• Acquired 71,770 shares of Common Stock at $2.09 per share (Direct)
  Date: 2025-04-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 94,497.00 | transaction_form_type: 4
• Acquired 22,727 shares of Common Stock at $4.17 per share (Direct)
  Date: 2024-06-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 22,727.00 | transaction_form_type: 4
• Acquired 63 shares of Series B Preferred Stock at $800.0 per share (Direct)
  Date: 2026-03-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 63.00 | transaction_form_type: 4
• Acquired 8,000 shares of Stock Options - Right to Buy at $5.0 per share (Derivative)
  Date: 2024-06-26 | Code: A | Expires: 2034-06-26 | Exercise: 2025-06-26 | equity_swap_involved: 0 | shares_owned_after: 8,000.00 | transaction_form_type: 4
• Acquired 247,522 shares of Series B Warrants at $0.3182 per share (Derivative)
  Date: 2026-03-16 | Code: A | Expires: 2029-03-16 | Exercise: 2026-03-16 | equity_swap_involved: 0 | shares_owned_after: 247,522.00 | transaction_form_type: 4